title: Clinical features and treatment outcome in Japanese patients with social anxiety disorder: chart review study.
abstract: The lifetime prevalence of social anxiety disorder (SAD) is high at 3-13%, but there have been only limited reports investigating the clinical features of this disorder in a large number of Japanese patients. The authors have conducted a retrospective, chart review study of 52 patients with SAD and obtained the following results. (i) The proportion of SAD in first visit outpatients at the Department of Psychiatry, Niigata University Medical and Dental Hospital, Niigata, Japan, was 1.04%. The male : female ratio was 1:0.73, so male patients appeared to be more common in the sample. (ii) With regard to subtype, generalized type (73% of the patients) was more common than non-generalized type (27%). (iii) The mean age of onset was 18.6 +/- 7.8 years, and there was a trend towards onset of disease at a younger age in the generalized type compared to the non-generalized type. (iv) The most common chief complaint was anxiety and tension in front of others (40.4%). (v) Pharmacotherapy resulted in improvement in 63.5% of the patients. Treatment by fluvoxamine and alprazolam resulted in high response rates of more than 70%.
authors.affiliation: Department of Psychiatry, Niigata University Medical and Dental Hospital, Niigata, Japan.
authors.forename: Masanobu
authors.initials: M
authors.lastname: Shindo
authors.forename: Toshiki
authors.initials: T
authors.lastname: Shioiri
authors.forename: Hidki
authors.initials: H
authors.lastname: Kuwabara
authors.forename: Maki
authors.initials: M
authors.lastname: Maruyama
authors.forename: Ryu
authors.initials: R
authors.lastname: Tamura
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Someya
mesh_terms: D000328:Adult; D017668:Age of Onset; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D011569:Psychiatric Status Rating Scales; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012931:Social Environment; D016896:Treatment Outcome
chemical_list: D014151:Anti-Anxiety Agents; D017367:Selective Serotonin Reuptake Inhibitors